AJDRAJNR - American Journal of Neuroradiology

Publication Preview: Published October 29, 2009
This Article
Free to Access This article has been Unlocked
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Ross, B.D.
Right arrow Articles by Sailasuta, N.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ross, B.D.
Right arrow Articles by Sailasuta, N.

METHODOLOGIC PERSPECTIVES

Hyperpolarized MR Imaging: Neurologic Applications of Hyperpolarized Metabolism

B.D. Ross, P. Bhattacharya, S. Wagner, T. Tran and N. Sailasuta

From the Huntington Medical Research Institutes, Pasadena, California; and Rudi Schulte Research Institute, Santa Barbara, California.

Please address correspondence to Brian D. Ross, MD, 10 Pico St, Pasadena, CA 91105; e-mail: Bdross.hmri{at}gmail.com

SUMMARY: Hyperpolarization is the general term for a method of enhancing the spin-polarization difference of populations of nuclei in a magnetic field. No less than 5 distinct techniques (dynamic nuclear polarization [DNP]; parahydrogen-induced polarization–parahydrogen and synthesis allow dramatically enhanced nuclear alignment [PHIP-PASADENA]; xenon/helium polarization transfer; Brute Force; 1H hyperpolarized water) are currently under exhaustive investigation as means of amplifying the intrinsically (a few parts per million) weak signal intensity used in conventional MR neuroimaging and spectroscopy. HD-MR imaging in vivo is a metabolic imaging tool causing much of the interest in HD-MR imaging. The most successful to date has been DNP, in which carbon-13 (13C) pyruvic acid has shown many. PHIP-PASADENA with 13C succinate has shown HD-MR metabolism in vivo in tumor-bearing mice of several types, entering the Krebs–tricarboxylic acid cycle for ultrafast detection with 13C MR imaging, MR spectroscopy, and chemical shift imaging. We will discuss 5 promising preclinical studies: 13C succinate PHIP in brain tumor; 13C ethylpyruvate DNP and 13C acetate; DNP in rodent brain; 13C succinate PHIP versus gadolinium imaging of stroke; and 1H hyperpolarized imaging. Recent developments in clinical 13C neurospectroscopy encourage us to overcome the remaining barriers to clinical HD-MR imaging.